Japan Cancer Vaccines Market
                     Japan Cancer Vaccines Market
Set to Exceed $1,470.4 Million by 2026 | CAGR 17.8%
“Japan Cancer Vaccines Market Share, Size, Trends, 
Industry Analysis Report, By Vaccine Type (Prevention 
Vaccines, Treatment Vaccines, Oncolytic Viruses); By 
Indication (Prostate Cancer, Cervical Cancer, Other); By 
Patient Type (Pediatric, Adult); Segments Forecast, 2020 - 
2026”
Japan Cancer Vaccines Market Estimate & Forecast to 2026
The Japan Cancer Vaccines market size is expected to reach USD 1,470.4 Million by 2026 
according to a new study by Polaris Market Research.
For several years now, Japan has been experiencing a boom in the incidence of cancer 
patients. Cancer is one of the major causes of death in Japan. As cancer prevention, the 
people in Japan mainly follow their traditional low-fat diet which has proven to be effective 
however, there are certain limitation to this as high salt in the Japanese diet can act as a 
potential risk for development of stomach cancer. Though Japanese government is 
promoting various new ways of prevention and treatment of the disease, implementation of 
cancer vaccines in the healthcare regime is a must and it is necessary for the government to 
take steps towards usage of these vaccines in Japan.
The primary factor driving the growth of this market in Japan is the growing rate of 
prevalence of incidence. According to the National Cancer Registry system, in 2016, around 
995,132 new patients were diagnosed with cancer of which 566,575 were men and 428,499 
were women. Each year, about 10,000 Japanese women are newly diagnosed with the 
disease while 3,000 die from it. With growing number of patients there is a rising need for a 
preventive measure that could help stabilize the increasing rate of incidence. Furthermore, 
growing government initiatives to generate awareness amongst people, and increasing 
research and development aCocpytriigvhti ©t iPeolasri sa Mrareke t aRelseaorc hf &u Ceonlsiunltigng  LtLhP 2e01 8g. Arllo Rwightsh Re soerfv edthis market in Japan. 2
 Japan Cancer Vaccines Market Scope
By Vaccine Type  By Indication By Patient Type By Region Report Attributes
I. Prevention Vaccines
I. HPV  Prostate Cancer  Pediatric  North America  Historic year: 2016-2018
II. HBV
II. Treatment Vaccines  Cervical Cancer  Adult  Europe  Base year: 2019
I. Antigen vaccines
II. Dendritic cell  Others  Asia Pacific  Forecast Year: 2020-2026
vaccines
III. DNA vaccines  Latin America Middle  Revenue ((USD Million)
IV. Whole tumor 
vaccines East & Africa 
V. Anti-idiotype 
vaccines
III. Oncolytic Viruses
Request for sample
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 3
Japan Cancer Vaccines Market Estimate & Forecast to 2026
Japanese government and many local and international companies are taking initiatives to 
develop the cancer vaccine industry in this region. In order to promote and develop 
regenerative medicine and cell therapy in Japan, the Act on the Safety of Regenerative 
Medicine and the Revised Pharmaceutical Affairs Law was enforced in November 2014. Also, 
Advanced Medical Care is accepted in Japan to evaluate a medical technology at one’s own 
expense, together with the National Health Insurance, at institutes and hospitals approved 
by the MHLW. The technological intervention includes regenerative medicine and 
immunotherapy, the safety and efficacy of which have not been established by previous 
clinical studies.
Furthermore, many companies are conducting clinical trials to develop and launch 
innovative vaccines that could help the cancer patients. Companies such as Cytlimic, Aduro 
Biotech, Oncolys BioPharma, and Otsuka are some of them who have initiated many 
projects focusing on enhancing their cancer vaccine product line. These initiatives have 
attracted international funding and thus has created significant growth opportunities for 
established and emerging players in the global and Japanese cancer vaccines market. The 
key players in the market include Aduro BioTech, Inc., Astellas Pharma, Inc., Bristol-Myers 
Squibb, tella, Inc., Oncolys BioPharma Inc., CYTLIMIC, Takeda Pharamceutical, and Takara Bio 
among others.
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 4
 
                                                                       
                                                                    Browse Complete Report
Japan Cancer Vaccines Market Size
Request for TOC
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 5
Japan Cancer Vaccines Market Study – Engagement Options
Buy Now – Click Here!
Buy now & have immediate access to premium insights
Purchase Report Sections – Click Here!
Regional analysis
Segmentation analysis
 Industry outlook
Competitive landscape
Speak To Analyst – Click Here!
Get your doubts clear
Schedule a call with our analyst before making any decision
Request For Sample Pages – Click Here!
Get free sample pages 
Understand report structure
Unmask data for validation
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 6
About Us
Polaris Market Research is a global market research and consulting company. The company 
specializes in providing exceptional market intelligence and in-depth business research services 
for our clientele spread across different enterprises. We at Polaris are obliged to e present across 
the industries of healthcare, technology, semi-conductors and chemicals among various other 
industries present around the world. 
We strive to provide our customers with updated information on innovative technologies, high 
growth markets, emerging business environments and latest business-centric applications, 
thereby helping them always to make informed decisions and leverage new opportunities. Adept 
with a highly competent, experienced and extremely qualified team of experts comprising SMEs, 
analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our 
customers.
 
Web: www.polarismarketresearch.com
Official Blog: http://ict-market-research.blogspot.com
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 7
Thank You!
Contact Us :
Polaris Market Research
30 Wall Street
8th Floor, 
New York City, NY 10005,
United States
E mail Id: [email protected]
Phone: +1-646-568-9980